Subramanya Hoshalli

Title: Subramanya Hoshalli: Innovator in Pharmaceutical Advancements

Introduction

Subramanya Hoshalli is a prominent inventor based in Bengaluru, India, recognized for his significant contributions to the field of pharmaceuticals. With a total of two patents to his name, his work focuses on innovative compounds that have the potential to revolutionize treatment approaches, particularly in oncology.

Latest Patents

Hoshalli's latest patents encompass critical advancements in the understanding and treatment of various diseases. His first patent, titled “Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways,” provides a novel approach to co-regulating these vital pathways by administering therapeutically effective amounts of these compounds. These compounds aim to address conditions related to the dysregulation of the RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways, with a notable application in cancer treatment.

The second patent, which deals with “Substituted amino-pyrimidine derivatives,” presents new substituted quinazoline and pyrido-pyrimidine compounds. This patent also emphasizes their dual function as PI3K/mTOR inhibitors, particularly in treating diseases characterized by inflammation or abnormal cellular proliferation, again with a focus on cancer.

Career Highlights

Currently, Subramanya Hoshalli is affiliated with Asana Biosciences, LLC, where he continues to build on his expertise in pharmacological research and development. His ability to innovate compounds that effectively target complex disease pathways highlights his substantial impact in the pharmaceutical industry.

Collaborations

Hoshalli has collaborated with esteemed colleagues, including Roger Astbury Smith and Scott Kevin Thompson, further enriching his research environment. These collaborations enable a sharing of knowledge and expertise, amplifying the potential for groundbreaking discoveries in medicine.

Conclusion

Subramanya Hoshalli stands out as a dedicated inventor within the pharmaceutical sector. His innovative patents and collaborative efforts reflect a commitment to advancing therapeutic solutions, particularly in the fight against cancer. As he continues his work at Asana Biosciences, his contributions are poised to significantly influence the landscape of medical treatments.